GANX · Gain Therapeutics, Inc.
Substantial doubt about the company's ability to continue as a going concern.
“Our projected cash outflows for the upcoming periods raise substantial doubt about our ability to continue as a going concern for at least 12 months from the issuance of the financial statements included elsewhere in this Quarterly Report.”View the 10-Q filed Aug 11, 2026
Positioning
Sep 18, 2026 · 23 days to expiryChain
Click any strike for greeks, breakeven and the calculator| Calls | Puts | |||||||||
|---|---|---|---|---|---|---|---|---|---|---|
| OI | Vol | IV | Δ | Last | Strike | Last | Δ | IV | Vol | OI |
| 71 | 2 | — | — | $1.00 | $0.10 | -0.112 | 627.6% | 3 | 2 | |
| 669 | 216 | 73% | 0.488 | $0.15 | $0.17 | -0.497 | 87.9% | 51 | 74 | |
| 206 | 10 | 162.5% | 0.199 | $0.07 | — | -0.837 | 147.4% | — | 0 | |
| 30 | 4 | 427.2% | 0.451 | $0.05 | — | -0.87 | 206.7% | — | 0 | |
| 17 | 17 | 519.6% | 0.472 | $0.05 | — | -0.884 | 252.2% | — | 0 | |
About this data
Each contract's last price, volume, greeks, implied volatility and open interest belongs to the snapshot session shown in its details; unknown means the provider omitted the timestamp. This chain has mixed snapshot sessions · Aug 11, 2026–Aug 25, 2026; 3 unknown. Cross-contract positioning totals are shown only when every returned row has the same known session. Bid and ask are not included on this plan.
In-the-money strikes are tinted, deepening toward the money, and the bar beside each open-interest figure scales to the heaviest strike shown.